The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men
暂无分享,去创建一个
A. Jakubowska | J. Lubiński | S. Narod | J. Kiś | K. Bar | B. Małkiewicz | M. Słojewski | R. Zdrojowy | C. Cybulski | D. Wokołorczyk | W. Kluźniak | T. Byrski | T. Borkowski | A. Borkowski | P. Milecki | T. Huzarski | J. Gronwald | T. Dębniak | B. Górski | W. Różański | M. Stawicka | H. Janiszewska | B. Masojć | M. Sosnowski | A. Sikorski | A. Antczak | T. Gromowski | A. Kashyap | A. Gołąb | B. Gliniewicz | J. Przybyła | J. Matych | J. Wilkosz | P. Sikorska‐Radek | Jacek Wilkosz
[1] Guozhen Qiu,et al. The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk , 2014, Tumor Biology.
[2] P. Jarzemski,et al. A common nonsense mutation of the BLM gene and prostate cancer risk and survival. , 2013, Gene.
[3] K. Muir,et al. A personalised approach to prostate cancer screening based on genotyping of risk founder alleles , 2013, British Journal of Cancer.
[4] P. Jarzemski,et al. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland , 2013, The Prostate.
[5] A Jakubowska,et al. An inherited NBN mutation is associated with poor prognosis prostate cancer , 2012, British Journal of Cancer.
[6] Peter Kraft,et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array , 2013, Nature Genetics.
[7] Kari Stefansson,et al. A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer , 2012, Nature Genetics.
[8] D. Easton,et al. Germline BRCA1 mutations increase prostate cancer risk , 2012, British Journal of Cancer.
[9] J. Carpten,et al. Germline mutations in HOXB13 and prostate-cancer risk. , 2012, The New England journal of medicine.
[10] A. Hamid,et al. Genetic polymorphism of the glutathione-S-transferase P1 gene (GSTP1) and susceptibility to prostate cancer in the Kashmiri population. , 2011, Genetics and molecular research : GMR.
[11] D. Easton,et al. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients , 2011, British Journal of Cancer.
[12] A. Jakubowska,et al. The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population , 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[13] I. Thompson,et al. Single and Multivariate Associations of MSR1, ELAC2, and RNASEL with Prostate Cancer in an Ethnic Diverse Cohort of Men , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[14] J. Lubiński,et al. Genetic heterogeneity of 8q24 region in susceptibility to cancer. , 2009, Journal of the National Cancer Institute.
[15] J. Morrison,et al. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer , 2009, British Journal of Cancer.
[16] John L Hopper,et al. Multiple loci with different cancer specificities within the 8q24 gene desert. , 2008, Journal of the National Cancer Institute.
[17] P Ghadirian,et al. Rapid progression of prostate cancer in men with a BRCA2 mutation , 2008, British Journal of Cancer.
[18] A. Jakubowska,et al. BRCA1 mutations and prostate cancer in Poland , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[19] Oliver Sieber,et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.
[20] David Reich,et al. A common genetic risk factor for colorectal and prostate cancer , 2007, Nature Genetics.
[21] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[22] J. Witte. Multiple prostate cancer risk variants on 8q24 , 2007, Nature Genetics.
[23] B. Tai,et al. RNASEL Gene Polymorphisms and the Risk of Prostate Cancer: a Meta-analysis , 2006, Clinical Cancer Research.
[24] J. Witte,et al. Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. , 2006, Human molecular genetics.
[25] J. Lubiński,et al. Population Screening for Cancer Family Syndromes in the West Pomeranian Region of Poland , 2006, Hereditary Cancer in Clinical Practice.
[26] A. Whittemore,et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. , 2005, American journal of human genetics.
[27] L. Kiemeney,et al. Site‐specific familial aggregation of prostate cancer , 2004, International journal of cancer.
[28] A. Jakubowska,et al. NBS1 Is a Prostate Cancer Susceptibility Gene , 2004, Cancer Research.
[29] David I. Smith,et al. Mutations in CHEK2 associated with prostate cancer risk. , 2003, American journal of human genetics.
[30] C. Wadelius,et al. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. , 1999, Pharmacogenetics.
[31] F. Hamdy,et al. Screening for Prostate Cancer , 2006 .
[32] T H Beaty,et al. Risk of cancer in relatives of prostate cancer probands. , 1995, Journal of the National Cancer Institute.
[33] T. Beaty,et al. Hereditary prostate cancer: epidemiologic and clinical features. , 1993, The Journal of urology.
[34] F. Gao,et al. The Prostate 69 : 662 ^ 688 ( 2009 ) AnUpdatingMeta-Analysis of the GSTM 1 , GSTT 1 , and GSTP 1 Polymorphisms andProstateCancer : AHuGEReview , 2009 .
[35] O. Brawley,et al. Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening , 2009, CA: a cancer journal for clinicians.
[36] J. Tyczynski,et al. Cancer in Poland. , 1993, Cancer detection and prevention.
[37] H T Lynch,et al. Hereditary breast cancer. , 1991, Annals of medicine.